Action plan: serialisation of Nordic packages focus on Product Codes

Similar documents
This standard operating procedure applies to stop smoking services provided by North 51.

A fake medicine that passes itself off as a real, authorised medicine. (1)

(Please text me on once you have submitted your request online and the cell number you used)

Rate Lock Policy. Contents

Annual Principal Investigator Worksheet About Local Context

How to become an AME Online

VOLUNTEER MOVE/CHANGE PROCESS. Volunteer Action Form is used to complete the following: To change companies or join a second company:

Record of Revisions to Patient Tracking Spreadsheet Template

Corporate Governance Code for Funds: What Will it Mean?

2017 CMS Web Interface

Editing Your Corps Page User Guide. BETA Version 1.0. The Salvation Army. Media Office

Completing the NPA online Patient Safety Incident Report form: 2016

Herbal Medicines: Traditional Herbal Registration

2017 CMS Web Interface

NATIONAL SENIOR CERTIFICATE GRADE 12

SUMMARY THE EUROPEAN COMMUNITY STRATEGY

NHAIS SIS Communication

FDA Dietary Supplement cgmp

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

The Cannabis Act and Regulations

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Indirect Sales. Proof Policy. Indirect Channel. Version May Author: Credit Risk & Fraud. External version

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

How to Get Set Up and Running with NDepend

CSE 331, Spring 2000

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE

EUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013

Call for evidence on the use of skin sensitisers, skin irritants and corrosive substances in textile and leather articles, hides and furs

2017 CMS Web Interface

Offshore CNY Guidelines

TABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.

British Sign Language (BSL) Plan October 2018 Scottish Charity Regulator

Meaningful Use Roadmap Stage Edition Eligible Hospitals

EMC believes the information in this publication is accurate as of its publication date. The information is subject to change without notice.

Medicare Quarterly Update Instructions

2018 CMS Web Interface

The Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017

Commissioning Policy: South Warwickshire CCG (SWCCG)

2018 CMS Web Interface

Annex III. Amendments to relevant sections of the Product Information

Swindon Joint Strategic Needs Assessment Bulletin

OPS Measurement Period Report

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Instructions and Helpful Information for D-5 Form. Preliminary Approval of Dissertation and Request for Oral Defense (D-5)

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS


PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

Who is eligible for LifeCare? What services are available?

Huon Logistics Isolation & Lockout Work Instruction 1. LOCKOUT DEVICES 2. LIGHT VEHICLE POSITIVE ISOLATION POINTS - 1 -

PACKAGE LEAFLET: INFORMATION FOR THE USER

2018 CMS Web Interface

Hearing Service Fees and Fee Codes Effective: January 01, 2019

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Creating and Linking Charge Objects

International Experts Meeting on Severe Accident Management in the Light of the Accident at the Fukushima Daiichi Nuclear Power Plant

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

All meetings and events held by, or on behalf of ESN Agder All ESN-related online activity All external representation of ESN and ESN Agder

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

Solaire Medical Electronic Lock Software

Hearing Conservation Program

Properties detailed info There are a few properties in Make Barcode to set for the output of your choice.

NATIONAL WEEK OF DEAF PEOPLE 19 th 25 th October 2013 EVENT QUIDELINES. Equality for Deaf People

InformationNOW Attendance

Vnr Statistics of the Year / wiki.vnr.fi

STANDARD FOR POMEGRANATE (CODEX STAN )

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

Lower Extremity Amputation (LEA) Considerations / Issues

SUFFOLK COUNTY COUNCIL. Anti- Social Behaviour Act Penalty Notice. Code of conduct

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction

Using the RC View DAT App

BRCA1 and BRCA2 Mutations

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benepali (etanercept): Brief training on additional Risk Minimisation Measures

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

2018 CMS Web Interface

If you have any doubts or queries about your medication, please contact your doctor or pharmacist.

IMMIGRATION Canada. Temporary Resident Visa. Los Angeles and New York City Visa Office Instructions. Table of Contents IMM 5876 E ( )

Childhood Immunization Status (NQF 0038)

CFS Private Sector modalities

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

Recommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012

Coding. Training Guide

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

Appendix C. Master of Public Health. Practicum Guidelines

Methadone Maintenance Treatment for Opioid Dependence

Statement of Work for Linked Data Consulting Services

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

MGPR Training Courses Guide

Transcription:

19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in an efficient manner als after the launch f everificatin. This dcument has been prepared by LIF Sweden and verified by all Nrdic cuntries. If yu have change requests t this dcument, please send them t: vnr@vnr.fi. The safety features required by the Falsified Medicines Directive (everificatin) will cnsist f a unique package identity carried by a 2D Data Matrix cmbined with tamper evidence. The 2D Data Matrix carries the fllwing elements Prduct cde (GTIN r unique NTIN) Unique serial number (randmized) fr every single physical package Batch number Expiry date EEA license plate: A 2D Data Matrix is printed n the pack tgether with the same infrmatin in human readable frmat # GTIN = Glbal Trade Item Number NTIN = Natinal Trade Item Number GTIN 1 = GTIN r Unique NTIN in this dcument Linear barcde = 1D cde carrier, which can hld either NTIN r GTIN 2D Data matrix = 2D cde carrier, which n the secndary pack, hlds Prduct cde (GTIN 1 ), Serial n, Batch n and Expiry date. Vnr = Nrdic Article Number, nt included in GTIN. Linkage between Vnr and GTIN 1 s is maintained in natinal data systems. EEA = Eurpean Ecnmic Area QRD = The Eurpean Medicines Agency's Wrking Grup n Quality Review f Dcuments Hard cut = A cut-ff date (ld packages need t be recalled) Cuntry requirements during pre-serialisatin phase and pst-serialisatin phase 1 GTIN (Glbal Trade Item Number) in this dcument means GTIN/Unique NTIN *Mre infrmatin abut abbreviatins http://www.ema.eurpa.eu/dcs/en_gb/dcument_library/regulatry_and_prcedural_guideline/2009/10/wc5 00004426.pdf # General infrmatin abut labelling, https://ec.eurpa.eu/health/sites/health/files/files/eudralex/vl- 2/2016_12_packaging_guidelines_revisin_14_4.pdf 1

General principles One GTIN 1 per secndary pack per stck keeping unit (SKU). DENMARK Pssibility: Keep current Vnr, keep current unique NTIN. Hard cut is needed at the mment when changing frm NTIN t GTIN 1 n packs (hard cut: cut-ff date, ld packages need t be recalled). Pharmacy systems hwever can NOT handle tw r mre GTIN 1 s fr the same Vnr at the mment. It is expected, that there will be a transitin phase, where there might be different slutins r wrkarunds at the pharmacies. It is expected, that the timeframe fr this transitin phase will be during Q2/Q3 2017. The legislatin in Denmark allws tw prduct cde carriers i.e. linear barcde / 2D Data Matrix n the same pack. The Danish Medicines Agency (DKMA) in Denmark has cnfirmed, that it is allwed t have a NTIN and a GTIN cntaining different number sequences (=prduct cde) n the secndary packaging. N DKMA submissin r apprval needed fr change frm NTIN t GTIN 1. Submissin t DKMAnet is needed if the Vnr is changed. Different GTIN 1 needed n the primary pack than n secndary pack (Amgrs in DK). N need t add a linear barcde / 2D Data Matrix n the primary packs fr ther cuntries. Please nte, that linear barcde n the primary pack will nt be affected by the serialisatin prject. GTIN change n the primary pack shuld be reprted t Amgrs. As nted abve, linear barcdes n the primary pack is nt part f the serialisatin prject. If a cmpany uses NTIN in the 2D Data Matrix, the NTIN shuld be unique and it shuld fllw the same rules fr changing as a GTIN. The unique NTIN must have been assigned befre February 9, 2019, as n new NTINs are assigned after this date. This means that the use f NTINs will diminish Please als see table n page 5. FINLAND N need t change Vnrs when changing frm NTIN t GTIN 1. N hard cut is needed when changing frm NTIN t GTIN 1 n packs (hard cut: cut-ff date, ld packages need t be recalled). Infrm new GTIN 1 s and changes f GTIN 1 s in the Vnr Service (can be dne at any time). Prduct cdes are delivered t the supply chain actrs frm the Vnr service. Many different GTIN 1 s are allwed fr the same Vnr in the data system at the same time. This is a ne-t-many relatin. N need fr Finnish Medicines Agency s (Fimea) submissin r apprval (if nly the prduct cde is changed). If the layut is changed, an Article 61(3) ntificatin needs t be submitted and apprved (3 mnths lead time). N need fr labelling texts fr natinally apprved prducts in Finland. Mck-ups are sufficient. 2

The Finnish Medicines Agency (Fimea) has added guidance n Intrductin f safety features n their website, e.g. when a ntificatin shuld be submitted fr an apprval http://www.fimea.fi/web/en/marketing_authrisatins/safety-features If a cmpany uses NTIN in the 2D Data Matrix, the NTIN shuld be unique and it shuld fllw the same rules fr changing as a GTIN. The unique NTIN must have been assigned befre February 9, 2019, as n new NTINs are assigned after this date. This means that the use f NTINs will diminish Please als see table n page 5. ICELAND N need t change Vnrs when changing frm NTIN t GTIN 1. Check where t infrm prduct cde changes. Tw different prduct cde carriers i.e. linear barcde / 2D Data Matrix are allwed n the packs at the same time (the pharmacies rder primarily n Vnrs). The prduct cde carriers must have the same cntent i.e. prduct cde. Submissin t Icelandic Medicines Agency needed fr infrmatin accrding t nrmal practice. If a cmpany uses NTIN in the 2D Data Matrix, the NTIN shuld be unique and it shuld fllw the same rules fr changing as a GTIN. The unique NTIN must have been assigned befre February 9, 2019, as n new NTINs are assigned after this date. This means that the use f NTINs will diminish Please als see table n page 5. NORWAY Backgrund: In 2017 Nrwegian IT systems are based n ne Vnr linked t ne prduct cde (linear barcde). The linear barcde is used by whlesalers and pharmacies as an identifier in the physical handling f the prduct in many different prcesses and are vital fr crrect dispensing. It is pssible t use either a NTIN r a GTIN 1, but the data systems are nt able t manage the transfer f ne cde (e.g. NTIN) t anther cde (e.g. GTIN) withut manual changes (by Farmalgg, the whlesalers and the pharmacies) and crrespnding risks and wrklad. The prblem is nt the intrductin f GTIN but a seamless handling f mre than ne prduct cde per Vnr. If NTIN is changed t GTIN in 2017, a new Vnr is required. N hard cut is needed (hard cut: cut-ff date, ld packages need t be recalled). The new Vnr must be enrlled in Farmalgg as substitutinal Vnr. The sales f the ld Vnr will cntinue until last pack is sld by the whlesaler. The sales will be transferred t the new Vnr when each whlesaler is ut f stck f the ld Vnr. When all whlesalers are ut f stck, the ld Vnr will be remved frm the register. Any new pack (Vnr) may have a GTIN. Changing NTIN t GTIN n a marketed pack (Vnr) shuld be avided until this can be handled by the data system. This change will ccur 1 Jan 2018. Frm 1 Jan 2018, new prduct cdes may be added t the data system by the pharma cmpanies. This functinality will be added n Farmalggs websites, VareWeb. An artwrk pdf must als be submitted at the website. If NTIN is changed t GTIN after January 1, 2018, several different prduct cdes are allwed in the data systems fr the same Vnr (ne-t-many relatin). 3

Packs released t the Nrwegian market befre 9 Feb 2019 must have a linear barcde, and may have 2D Data Matrix. Packs released t the Nrwegian market after 9 Feb 2019 must have 2D Data Matrix and must nt have linear barcde. Cmpanies wh need time t remve the linear barcde after 9 Feb 2019 shuld agree this with the Nrwegian Medicines Agency. If the layut f artwrk is changed due t the intrductin f 2D Data Matrix, an Article 61(3) ntificatin must be submitted t the Nrwegian Medicines Agency. If GTIN is included n the primary pack, it must be different t the GTIN n the secndary pack. Frm the beginning f 2018, prduct cdes fr primary packs may be added t the data system by the pharma cmpanies. This functinality will be added n Farmalggs website, VareWeb. An artwrk pdf must als be submitted at the website. If a phama cmpany uses NTIN in the 2D Data Matrix, the NTIN shuld be unique and it shuld fllw the same rules fr changing as a GTIN. The unique NTIN must have been assigned befre February 9, 2019, as n new NTINs are assigned after this date. This means that the use f NTINs will diminish Please als see table n page 5. SWEDEN N need t change Vnrs when changing frm NTIN t GTIN 1. N hard cut is needed when changing frm NTIN t GTIN 1 n packs (hard cut: cut-ff date, ld packages need t be recalled). Change NTIN t GTIN 1 by adding the new prduct cde in Leverantörernas infrmatin i VARA (LiiV). Many different GTIN 1 s are allwed fr the same Vnr in the data system at the same time (prduct cdes are just added in LiiV and the VARA-file stres them as previus/histrical prduct cdes). This is a ne-t-many relatin. If nly GTIN 1 is changed n ntificatin/variatin needed. If the layut is changed, an Article 61(3) ntificatin needs t be submitted and apprved (3 mnths lead time). T update labelling: ntificatin fr infrmatin nly r an Article 61(3) ntificatin is needed Please nte! A labelling text needs t be created fr all natinal packs that d nt have a labelling text. https://lakemedelsverket.se/malgrupp/fretag/lakemedel/nya-gdkannanden-andringar-chfrnyelser/krav-pa-sakerhetsdetaljer-pa-lakemedelsfrpackningar/) If a cmpany uses NTIN in the 2D Data Matrix, the NTIN shuld be unique and it shuld fllw the same rules fr changing as a GTIN. The unique NTIN must have been assigned befre February 9, 2019, as n new NTINs are assigned after this date. This means that the use f NTINs will diminish Please als see table n page 5. 4

Cuntry requirements regarding changes frm NTIN t GTIN 1 DK FI IS NO SE New Vnr required N* N N Hard cut required (cut-ff date, ld packages need t be recalled) when n change f Vnr, nly change f NTIN t GTIN 1 Hard cut required (cut-ff date, ld packages need t be recalled) when change f Vnr + change f NTIN t GTIN 1 Natinal data system updates required (change NTIN t GTIN 1 ) Many different prduct cdes (GTIN 1 s) fr the same Vnr can be handled by the natinal data system (ne-t-many relatin) Tw different prduct cde carriers (linear barcde and 2D Data Matrix) with the same GTIN 1 are allwed t be printed n the secndary pack at the same time Art 61(3) needed if layut change Infrmatin frm side/bttm panel can be deleted withut an Article 61(3), if the same text is already written smewhere else Natinal cmpetent authrity ntificatin including mck-up required fr change in barcde, Vnr r 2D Data Matrix Labeling text (QRD) required fr natinally apprved prducts *Fr further infrmatin see cuntry specific text abve. * at the mment N N in 2017 N frm 2018 * in 2017 N frm 2018 * N N N N Whlesaler N* (nt fr the same Vnr) at the mment PIC Will be updated later Farmalgg N in 2017 in 2018 N N LiiV N, if there is an apprved variatin N N N N N N (all updated artwrks need t be submitted) Nt knwn yet N N 5

Fr mre infrmatin regarding everificatin, see VnrWiki r cntact: DK: nvn@dli.dk FI: inf@laakevarmennus.fi IS: Benedikt Haukssn, benedikt@gs1.is NO: pst@nmvec.n SE: everifikatin@lif.se 6